(Credit-Canva)
We are always told to never mix work and friendships in social settings. While it is normal to make friendships at work, you should always keep a professional distance to make sure things do not go sour and start affecting your work. This also means that you do not divulge private information or have private conversations with your colleagues as you may never know how this could be brought up and affect you. This is an unsaid rule in corporate culture that if you are sick or you are coming down with a serious issue, you should never bring it up and keep it to yourself. While this may seem unusual to new workers, it is a very common knowledge for people who have been in the industry for a long time. A new study showed that this is much more common than many people believe!
A new poll shows that a lot of U.S. workers with long-term health problems keep it a secret from their bosses. This affects their health and their jobs. It's a big problem that employers could help fix, which would be good for everyone. This isn't just about people having a sniffle. We're talking about serious conditions like heart disease, diabetes, and asthma that require ongoing management and can significantly impact a person's life, both inside and outside of work. The fact that so many people feel they need to hide these conditions shows a larger issue of stigma and lack of support in the workplace.
Most U.S. workers which were over half of the people, have some kind of long-term health problem. But a lot of them, about 6 out of 10, don't tell their boss. They might be afraid their boss will treat them differently or think they can't do their job. Keeping secrets like this can make it hard to get the help you need at work. It can also make your health problems worse because you're stressed about hiding them. It's a tough situation, and it shows that many workplaces aren't as supportive as they could be.
The poll also found that more than a third of people with health problems have had to miss doctor's appointments because of work. This means they're putting their jobs ahead of their health, which isn't good. It's hard to balance work and health, especially when you have a long-term illness. People need understanding bosses who will let them take time off for important medical stuff. Missing appointments can make health problems worse, and it can also make people feel more stressed and anxious.
Almost half of the workers with health problems said they couldn't even take breaks during the day to take care of themselves. They also said they felt like they'd been passed over for promotions because of their health. And some people even got bad reviews at work because of their health problems. This can make people feel really bad about themselves and their jobs. It can also make their health problems worse because they're so stressed. It's not fair, and it's something that needs to change.
It's not just people with health problems who have a hard time. Lots of people are also taking care of someone at home who is sick. Almost half of these caregivers have to help their sick family member during work hours. And many of them have trouble taking time off to care for their loved ones. Some people even have to work fewer hours, which means less money. This shows how much pressure people are under, trying to juggle work and family and health.
Credit: AI
When we think of perimenopause, irregular periods, hot flashes and mood changes usually come to mind. But the transition to menopause is not limited to the menstrual cycle. Behind the scenes, changing ovarian hormones—particularly fluctuating and eventually declining estrogen—can influence body composition, insulin sensitivity, cholesterol levels, bone health and cardiovascular risk.
For many women, these metabolic changes begin years before their final menstrual period.
A common concern during perimenopause is: “I haven’t changed my diet, so why am I gaining weight around my abdomen?”
Ageing itself contributes to gradual loss of muscle mass and changes in energy expenditure. At the same time, the menopausal transition is associated with a shift in fat distribution, with a greater tendency to accumulate visceral or abdominal fat.
This matters because visceral fat is metabolically active. An increase in abdominal fat can be associated with insulin resistance, abnormal cholesterol levels and a higher risk of metabolic disease. So, the change in waist circumference may sometimes tell us more about metabolic health than the number on the weighing scale alone.
Also read: After Menopause, These Breast Changes Shouldn’t Be Ignored
Estrogen interacts with several pathways involved in glucose and fat metabolism. During midlife, changes in body composition, reduced physical activity, sleep disturbance and hormonal changes can collectively make insulin sensitivity less favourable.
This does not mean every woman going through perimenopause will develop diabetes. However, women who already have risk factors—such as overweight or obesity, prediabetes, a history of gestational diabetes or a strong family history of type 2 diabetes—should be particularly mindful.
The menopausal transition can also be accompanied by unfavourable changes in the lipid profile, including changes in LDL cholesterol. Cardiovascular risk increases with age, and menopause is an important time to reassess risk factors such as blood pressure, glucose, cholesterol, smoking, physical activity and body composition.
Women often spend years focusing on reproductive health while overlooking these equally important metabolic markers.
Also read: World Menopause Day: Is It Empty Nest Syndrome Or Menopause Symptoms? Expert Explains
Midlife is also an important period for protecting muscle and bone. Declining estrogen after menopause accelerates bone loss, while ageing contributes to loss of muscle mass.
Resistance training therefore becomes especially valuable. Adequate protein intake, regular weight-bearing exercise, sufficient calcium and vitamin D, good sleep and avoiding smoking can support healthier ageing.
Perimenopause should not be viewed as a disease, nor should every symptom or kilogram gained in midlife automatically be blamed on hormones. Instead, it is an opportunity for a metabolic health check.
Women should discuss appropriate screening for blood pressure, blood glucose or HbA1c, lipid profile, weight and waist circumference monitoring , DEXA scan for bone health, depending on their individual risk factors.
Most importantly, don’t wait for menopause to start thinking about metabolic health. The perimenopausal years can be an important window to build muscle, improve fitness, optimise nutrition and identify metabolic risk early.
Perimenopause is more than a change in periods—it is a transition in whole-body health. Understanding these changes early can help women enter the next phase of life stronger, healthier and better prepared.
(By Dr. Seema Daksh, MBBS, MD (Internal Medicine), DM (Endocrinology), Consultant Endocrinologist,Kailash Hospital, Greater Noida)
Credit: AI image
From haunted houses and sudden scares to sweet treats and costumes, Halloween fun can come with hidden health risks, particularly for people with existing heart and lung conditions.
Experts explain how sudden fright, excessive sugar and common activities on Halloween, observed on October 31, can affect heart and lung health.
A sudden scare activates the body's sympathetic nervous system, raising heart rate and blood pressure while constricting blood vessels.
This response is usually harmless in healthy people, but may pose risks for those with arrhythmias, coronary artery disease or a history of stents or heart surgery.
A racing heartbeat should settle after the scare. Persistent palpitations, dizziness, shortness of breath, chest pain or tightness, nausea, sweating or fainting warrant medical attention, says Dr Mohamed Gabr, cardiologist and electrophysiologist at Baylor College of Medicine.
In addition, excessive consumption of sugar candies during Halloween can contribute to obesity, diabetes, high blood pressure and unhealthy cholesterol levels. Cholesterol and plaque buildup in the coronary arteries can begin at a young age.
Also read: You Feel Healthy. But Plaque May Already Be Building In Your Arteries In Your 20s
Halloween activities can expose people with asthma to several triggers. Ragweed pollen, mould on damp fallen leaves and cold, dry air can worsen symptoms during autumn, according to the American Lung Association.
Fog machines and dry ice effects in haunted houses can release water droplets and chemicals, including glycol-based solvents, that may irritate airways. Glitter machines, bonfire smoke, dust from stored costumes and decorations, and strong fragrances can also trigger symptoms.
Dr Rubabin Tooba, a pulmonologist with Northwestern Medicine, says these exposures may cause coughing, wheezing, breathlessness and chest tightness, particularly in people with asthma, severe allergies or COPD. Tight-fitting masks can also make breathing difficult.
Fear, excitement and laughter may trigger asthma symptoms in some people. Trick-or-treating can bring additional exposure to pet dander, scented candles, cigarette smoke and fireplace fumes.
Read More: Why Are Asthma Cases Rising Among Young Kids? Early Symptoms Parents Must Not Ignore
The US Consumer Product Safety Commission (CPSC) estimates that an annual average of 3,200 Halloween-related injuries were treated in US emergency departments over a recent three-year period.
Pumpkin carving accounted for 55% of these injuries, while 25% were related to falls while putting up decorations, tripping on costumes or walking while trick-or-treating. The remaining 20% involved lacerations, ingestions, allergic reactions and other costume- or decoration-related injuries.
Children younger than 18 years accounted for 46% of injuries, with approximately 10% occurring in children aged 6 years or younger.
The Plastic Hand Trauma Unit at Royal Devon and Exeter Hospital has also treated patients with deep cuts, severed tendons and nerve damage from pumpkin carving, BBC reported.
Credit: iStock
When a couple has difficulty conceiving, thyroid checks are among the first things doctors do. Yet, it is an important fact that one often forgets - overt hypothyroidism or mild/subclinical hypothyroidism are actually very different things.
Having a thyroid that is not active enough means the body is not producing enough thyroid hormones. These hormones regulate metabolism and at the same time can greatly affect the functioning of the reproductive system like the occurrence and regularity of the menstrual cycle, ovulation and the hormonal environment that is necessary for pregnancy. Still, new findings suggest that we should not always take the blame for infertility just because the TSH level is borderline or abnormal.
Undiagnosed, overt hypothyroidism has the potential to disrupt reproduction in many ways. Lower levels of thyroid hormones may alter the balance in hypothalamic-pituitary-ovarian axis, which would affect ovulation and menstruation. In severe cases of hypothyroidism, higher prolactin levels could be observed, disrupting endocrine signaling.
According to new 2026 American Thyroid Association guidelines, overt hypothyroidism is considered to be a known risk factor for infertility and recurrent miscarriages. Specifically, according to the guideline, menstrual problems have been seen in 23% of women with untreated overt hypothyroidism, and about 2–3% of all cases of anovulation are due to hypothyroidism.
It is important to note that women with known hypothyroidism, who received appropriate treatment with levothyroxine and were in a euthyroid state, had the same chances for fertility as women without thyroid disorder.
Thus, the message here is not that women with hypothyroidism are unable to conceive. It is that thyroid dysfunction should not go untreated during planning of pregnancy.
Also read: World Iodine Deficiency Day: Significance And Importance
This is where the science becomes considerably more interesting.
Subclinical hypothyroidism generally means that TSH is elevated while free T4 remains within the normal range. It is increasingly detected during fertility investigations, partly because women are being tested more frequently.
A 2025 review article published in Current Opinion in Obstetrics & Gynecology concluded there isn't enough reliable evidence at this time to consider subclinical hypothyroidism as a contributor to infertility. It was also found that the use of levothyroxine was not consistently tied to improved pregnancy or live-birth outcomes in women suffering from subclinical hypothyroidism. The authors advocated for screening and treatment practices that are selective rather than universal.
This new recommendation represents a clear departure from the previous approach that was often overly aggressive in treating women with marginal thyroid test results.
The same findings were reported in a randomized trial-based 2024 systematic review and meta-analysis, which was published in a leading international medical journal by the world's largest academic medical publisher. The analysis showed that preconception levothyroxine administration had no statistically significant effect on live birth rates or pregnancy or miscarriage rates in subclinical hypothyroid women. Still, it should be mentioned that the scientists have recognized this issue and they have pointed out that for women with a TSH level above 4 mIU/L, the evidence is even more uncertain and that better trials are needed.
Also read: World Menopause Day: Is It Empty Nest Syndrome Or Menopause Symptoms? Expert Explains
A quite relevant study published in Human Reproduction in July of the same year examined 412 women who were subclinically hypothyroid and had frozen embryo transfers. In this group, 198 got levothyroxine whereas the other 214 were untreated. The live-birth rates were 43.9% for levothyroxine users against 39.3% in the untreated group. Even though the numbers were better for the treated group, the difference was not statistically significant.
It is also remarkable that apart from the levothyroxine group, they got other embryological results as well, including more fertilised oocytes, Day-3 embryos, good-quality Day-3 embryos and blastocysts. Yet it didn't lead to statistical significance of the live births. It's a typical point in fertility medicine that even if lab or embryological indicators are enhanced, it doesn't necessarily mean having more children.
In addition, the study carried out in 2026 on women undergoing the procedure of assisted reproduction, who left untreated, revealed that women with untreated TSH between around 3.6 and 6 mIU/L retrieved fewer oocytes. Yet, the live-birth rates after accounting for other factors turned out to be no significant difference at all (1,2).
In fact, there was quite a relevant study carried out recently on the effect of levothyroxine on the frozen embryo transfer (FET) outcomes in cases of subclinical hypothyroidism. It was conducted in Human Reproduction in July 2026. The participants of the study were 412 hypothyroid women who were undergoing FET (frozen embryo transfer).
Some evidence is emerging from here, but it should not yet be presented as an undisputed scientific fact.
On a big research scale with 2,867 women who were in the first IVF treatment cycle, it turned out that women who had subclinical or even overt hypothyroidism had their ovarian function decline much more than normal women, which was assessed through AMH and antral follicle count independent of thyroid autoimmunity. Though being an observational study, it just indicates the presence of a connection but not that hypothyroidism is causing the ovarian reserve to diminish.
The reason for drawing up such a clear line between them is that fertility depends on age, female factors like ovarian reserve, endometriosis PCOS, tubal factors, male factors like sperm quality, metabolic health and many other variables. Thyroid function is just one aspect out of a large puzzle not the complete picture
What about Hashimoto's and thyroid antibodies?
Thyroid autoimmunity is another contributing factor. There are cases where some females have thyroid antibodies, specifically thyroid peroxidase antibodies, even when the thyroid hormones of the individual are within normal range.
There is an inconclusive body of evidence associating the existence of thyroid antibodies with difficulty conceiving. In a review conducted in 2025, there was no substantial evidence that would support routine screening for every infertile female. The more recent 2026 ATA guidelines highlight the importance of taking into consideration the individual needs of the patient.
Not necessarily in exactly the same way.
A thyroid assessment is particularly important for women with a previous thyroid disorder, symptoms suggestive of hypothyroidism, irregular menstrual cycles, infertility, recurrent pregnancy loss, autoimmune disease or a family history of thyroid disease.
Recent Indian health coverage has also highlighted the importance of checking thyroid function during preconception care. A January 2026 Hindustan Times report noted the association between thyroid dysfunction and menstrual irregularities, infertility and recurrent miscarriage, while recommending greater awareness around testing during preconception and early pregnancy.
Thyroid gland is the most misused organ when it comes to health, Mainly when it comes to treatment.
When a woman suffers from uncorrected overt hypothyroidism, this can clearly interfere with fertilization by causing ovulation and monthly cycle irregularities and affecting fertility generally, which needs to be corrected before pregnancy whenever it is feasible. Generally, fertility results are encouraging after thyroid hormone levels are kept within the normal range.
In case of very mild to subclinical hypothyroidism In particular when the TSH is only a little bit above the normal levels and free T4 remains stable, the situation is far from a textbook case and it is rather a grey zone. However, new research conducted in 2025 and 2026 increasingly supports the idea of going beyond a one-size-fits-all prescription of levothyroxine to women with borderline TSH.
The only reasonable course of action for a woman who wants to conceive is as simple as: assess thyroid function clinically only when it is necessary (i.e., when there are clinical signs/symptoms of thyorid imbalance/ disease). Determine if the imbalance is one of those that are clinically overt (like signs and symptoms of overt hypothyroidism, elevated TSH, etc.) or clinically subclinical, then consider the TSH level, symptoms, thyroid antibodies, reproductive history, etc., and refer the treatment to an endocrinologist or fertility specialist to decide.
The goal is not to chase an arbitrary “perfect” TSH number. The goal is to identify genuine thyroid disease, treat it appropriately and avoid allowing either an untreated disorder or unnecessary treatment to become another source of anxiety during an already stressful fertility journey.
© $2026 Times Horizon Private Limited